Search research articles
Contact Us
Filters
Showing results (141-150 of 473) with videos related to
Page
of 48
Sort By:
Antibiotics (Basel, Switzerland)
|
June 27, 2024
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and <i>Pseudomonas aeruginosa</i> from Intensive Care Unit and Non-Intensive Care Unit Patients
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
The Journal of Antimicrobial Chemotherapy
|
February 17, 2009
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
Ronald N Jones, Gary J Moet, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
March 24, 2018
Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014
M A Pfaller, H S Sader, R K Flamm, et al.
International Journal of Antimicrobial Agents
|
March 7, 2018
In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme
Michael A Pfaller, Michael D Huband, Rodrigo E Mendes, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 25, 2004
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program
M Castanheira, A C Gales, R E Mendes, et al.
Phytopathology
|
October 24, 2008
Conidia as a Substrate for Internal Transcribed Spacer-Based PCR Identification of Members of the Leptosphaeria maculans Species Complex
M H Balesdent, M Jedryczka, L Jain, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
November 4, 2000
In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams
R K Roland, R E Mendes, S Silbert, et al.
Journal of Global Antimicrobial Resistance
|
July 24, 2017
Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015)
Michael A Pfaller, Rodrigo E Mendes, Helio S Sader, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016
Michael A Pfaller, Martin Cormican, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 11, 2015
Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptide
Ronald N Jones, John D Turnidge, Greg Moeck, et al.
Page
of 48
Search research articles
Search
Showing results (141-150 of 473) with videos related to
Sort By:
Page
of 48
Antibiotics (Basel, Switzerland)
|
June 27, 2024
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and <i>Pseudomonas aeruginosa</i> from Intensive Care Unit and Non-Intensive Care Unit Patients
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
The Journal of Antimicrobial Chemotherapy
|
February 17, 2009
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
Ronald N Jones, Gary J Moet, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
March 24, 2018
Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014
M A Pfaller, H S Sader, R K Flamm, et al.
International Journal of Antimicrobial Agents
|
March 7, 2018
In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme
Michael A Pfaller, Michael D Huband, Rodrigo E Mendes, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 25, 2004
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program
M Castanheira, A C Gales, R E Mendes, et al.
Phytopathology
|
October 24, 2008
Conidia as a Substrate for Internal Transcribed Spacer-Based PCR Identification of Members of the Leptosphaeria maculans Species Complex
M H Balesdent, M Jedryczka, L Jain, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
November 4, 2000
In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams
R K Roland, R E Mendes, S Silbert, et al.
Journal of Global Antimicrobial Resistance
|
July 24, 2017
Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015)
Michael A Pfaller, Rodrigo E Mendes, Helio S Sader, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016
Michael A Pfaller, Martin Cormican, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 11, 2015
Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptide
Ronald N Jones, John D Turnidge, Greg Moeck, et al.
Page
of 48